Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Novartis settles with...

    Novartis settles with US over China bribe claims

    Written by savita thakur thakur Published On 2016-03-25T12:10:26+05:30  |  Updated On 25 March 2016 12:10 PM IST
    Zurich: Swiss drugmaker Novartis said Thursday it had reached a deal with US authorities to pay $25 million (22.4 million euros) to settle claims that its Chinese units bribed healthcare professionals to boost sales, including with family trips to Niagara Falls.

    The drug giant agreed to pay the hefty fine "without admitting or denying" guilt, according to documents published by the US Securities and Exchange Commission (SEC).

    According to the SEC findings, Novartis's China-based units had between 2009 and 2013 "provided things of value" mainly to doctors and other healthcare professionals.

    "These payments took varied forms and were intended to increase sales of Novartis pharmaceutical products," said an SEC document filed late Wednesday.

    The market regulator said healthcare providers were for instance invited on expensive trips, which in many cases "did not include an educational purpose or the scientific/educational components were minimal in comparison to the sightseeing or recreational activities."

    In 2009, Novartis subsidiary Sandoz China for instance paid for 25 healthcare workers to take part in a surgical conference in Chicago, inviting along their spouses and taking the group on an excursion to the Niagara Falls. Each participant also received $150 in pocket money, the SEC document said.

    Employees and managers at the involved units had tried to "conceal the true nature of the transactions", by for instance "improperly recording payments as legitimate expenses" for things like travel, entertainment, conferences and medical studies.

    Novartis, which is listed on the New York Stock Exchange, thus stands accused of breaching the US Securities Exchange Act by not keeping accurate books and failing to maintain a sufficient system of internal accounting controls."

    But the SEC noted that Novartis had cooperated with its investigation and opened its own internal probe, letting go or disciplining employees found at fault.

    It has also since put stepped up its control mechanisms, the SEC said.

    The pharmaceutical giant itself acknowledged the deal with the SEC, but stressed that the incidents in question "largely pre-date many of the compliance-related measures introduced by Novartis across its global organisation in recent years."

    "We believe these measures, which we review and update on an ongoing basis, address the issues raised by the SEC," Novartis spokesman Eric Althoff told
    briberybribes to doctorsEric AlthoffNew York Stock ExchangeNovartisSECSecurities and Exchange CommissionSecurities Exchange Act
    Source : AFP

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok